3,5-aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as S1P receptor agonists

Details for Australian Patent Application No. 2004277947 (hide)

Owner Merck & Co., Inc.

Inventors Doherty, George A.; Hale, Jeffrey J.; Lynch, Christopher L.; Toth, Leslie M.; Legiec, Irene E.

Agent Spruson & Ferguson

Pub. Number AU-A-2004277947

PCT Pub. Number WO2005/032465

Priority 60/507,622 01.10.03 US

Filing date 27 September 2004

Wipo publication date 14 April 2005

International Classifications

A61K 31/4245 (2006.01) - Oxadiazoles

C07D 271/06 (2006.01) Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/032465 Priority application(s): WO2005/032465

24 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004277951-Solubilized CoQ-10

2004277946-Bone plates with hole for interchangeably receiving locking and compression screws